Open Access · CC BY-NC-ND 4.0
Gut dysbiosis: An overlooked pharmacokinetic modifier in psychotropic therapy
Precision Medication · 2026-06 · 3 (2) · 100098
DOI: 10.1016/j.prmedi.2026.100098 ↗Kurz gefasst
Fachartikel in der Zeitschrift Precision Medication, 2026-06. Verfasst von Mohammed Khaled Al Alaili. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Alaili, M. K. A. (2026). Gut dysbiosis: An overlooked pharmacokinetic modifier in psychotropic therapy. Precision Medication, 3(2), 100098. https://doi.org/10.1016/j.prmedi.2026.100098
Vancouver
Alaili MKA. Gut dysbiosis: An overlooked pharmacokinetic modifier in psychotropic therapy. Precision Medication. 2026;3(2):100098. doi:10.1016/j.prmedi.2026.100098
BibTeX
@article{Alaili2026,
author = {Alaili, Mohammed Khaled Al},
title = {Gut dysbiosis: An overlooked pharmacokinetic modifier in psychotropic therapy},
journal = {Precision Medication},
year = {2026},
volume = {3},
number = {2},
pages = {100098},
doi = {10.1016/j.prmedi.2026.100098}
}
EUVIMED